Flizasertib
Flizasertib is a serine/threonine kinase inhibitor[1].
Product Specifications
CAS Number
[2268739-68-8]
Product Name Alternative
GDC-8264
UNSPSC
12352005
Target
Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/flizasertib.html
Purity
99.9
Solubility
10 mM in DMSO
Smiles
F[C@@H]1C2=NC(C(C3CC3)=O)=NN2[C@H](C4=CC=CC=C4)C1
Molecular Formula
C15H14FN3O
Molecular Weight
271.29
References & Citations
[1]WHO Drug Information-World Health Organization (WHO) .
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E3373-05C-HRP 100 µL
EphB4 (Ephrin type-B receptor 4, HTK, MYK1, Tyro11, TYRO11) (HRP)
Ask
View Details 
MBS1093236-01 0.02 mg (E-Coli)
Recombinant Human respiratory syncytial virus B Phosphoprotein (P)
Ask
View Details MBS1093236-02 0.1 mg (E-Coli)
Recombinant Human respiratory syncytial virus B Phosphoprotein (P)
Ask
View Details MBS1093236-03 0.02 mg (Yeast)
Recombinant Human respiratory syncytial virus B Phosphoprotein (P)
Ask
View Details